Patents by Inventor Christopher James Ward

Christopher James Ward has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Systems and methods of direct data storage for measurement instrumentation
    Patent number: 11818210
    Abstract: Systems and methods of writing data acquired from measurement instrumentation. Embodiments include establishing a direct data connection between the test equipment and a network storage drive, generating test data from a sample under test, and writing the test data to the network storage drive without assistance of a computerized controlling device configured to control the testing device.
    Type: Grant
    Filed: October 7, 2019
    Date of Patent: November 14, 2023
    Assignee: Advanced Measurement Technology, Inc.
    Inventors: Christopher James Ward, Brian Sayers
  • Method for detecting fluoride
    Publication number: 20040018631
    Abstract: A method for detecting the presence and/or amount of fluoride in a test sample which comprises contacting the test sample with a compound of Formula (1) or a salt thereof and evaluating any change in the spectral characteristics of the compound:
    Type: Application
    Filed: August 8, 2003
    Publication date: January 29, 2004
    Inventors: Christopher James Ward, Prakash Patel, Tony David James
  • Tuberous sclerosis 2 gene and uses thereof
    Patent number: 6232452
    Abstract: Tuberous sclerosis (TSC) is an autosomal dominant disorder characterised by widespread development of growths in many tissues and organs. A gene (TSC2) is identified on chromosome 16 which is mutated in TSC and which may behave as a tumour suppressor. Screening of actual or suspected TSC patients for normal or mutated TSC2 can be used for diagnostic purposes. TSC2 protein (tuberin) may be used to treat or prevent unrestrained cell division and/or tumour development in patients with or without TSC.
    Type: Grant
    Filed: October 1, 1996
    Date of Patent: May 15, 2001
    Inventors: Julian R. Sampson, Mark David Nellist, Phillip Brook-Carter, Magitha Maheshwar, Dirkje Jorijntje Johanna Halley, Lambertus Antonius Jacobus Janssen, Arjenne Lique Wilhelma Hesseling, Anna Maria Wilhelmina van den Ouweland, Peter Charles Harris, Christopher James Ward, Martin Hendrik Breuning, Jeroen Hendrik Roelfsema
  • Tuberous sclerosis 2 gene and uses thereof
    Patent number: 6207374
    Abstract: Tuberous sclerosis (TSC) is an autosomal dominant disorder characterised by widespread development of growths in many tissues and organs. A gene (TSC2) is identified on chromosome 16 which is mutated in TSC and which may behave as a tumour suppressor. Screening of actual or suspected TSC patients for normal or mutated TSC2 can be used for diagnostic purposes. TSC2 protein (tuberin) may be used to treat or prevent unrestrained cell division and/or tumour development in patients with or without TSC.
    Type: Grant
    Filed: March 18, 1998
    Date of Patent: March 27, 2001
    Assignee: Medical Research Council
    Inventors: Julian R. Sampson, Mark David Nellist, Phillip Brook-Carter, Magitha Maheshwar, Dirkje Jorijnte Johanna Halley, Lambertus Antonius Jacobus Janssen, Arjenne Lique Wilhelma Hesseling, Anna Maria Wilhelmina van den Ouweland, Peter Charles Harris, Christopher James Ward, Martin Hendrik Breuning, Jeroen Hendrik Roelfsema